LncRNA GAS5 ameliorates intestinal barrier injury by targeting the miR-223-3p/FBXW7 axis and inactivating NF-κB signaling in vitro and in vivo
- PMID: 40719162
- DOI: 10.1002/path.6440
LncRNA GAS5 ameliorates intestinal barrier injury by targeting the miR-223-3p/FBXW7 axis and inactivating NF-κB signaling in vitro and in vivo
Abstract
Sepsis is a potentially lethal syndrome that leads to multiple organ dysfunction. LncRNA GAS5 is closely related to sepsis; however, its detailed functions and mechanism in sepsis-triggered intestinal barrier dysfunction are unclear. In this study, NCM460 cells were stimulated with lipopolysaccharide (LPS) to mimic septic intestinal injury in vitro, and a sepsis mouse model was established via the cecum ligation and perforation method. Terminal deoxynucleotidyl transferase dUTP nick end labeling staining was performed for cell apoptosis evaluation. RNA and protein levels were examined by RT-qPCR and western blotting, respectively. Additionally, cell permeability and intestinal mucosa permeability were measured. ELISA was utilized to detect inflammatory cytokine production. H&E staining was conducted for histologic examination of the intestine. Luciferase reporter and RNA pull-down assays were employed to verify the interaction between GAS5, miR-223-3p, and FBXW7. The results showed that GAS5 was downregulated in LPS-exposed NCM460 cells as well as the intestine of septic mice. GAS5 overexpression mitigated LPS-triggered intestinal epithelial cell damage and apoptosis in vitro and reduced pathological damage, inflammation, and intestinal hyperpermeability in septic mice. GAS5 upregulated FBXW7 by interacting with miR-223-3p. Depletion of FBXW7 reversed the protective effects of GAS5 overexpression in vitro. Additionally, GAS5 overexpression inactivated NF-κB signaling in LPS-stimulated NCM460 cells. NF-κB inactivation exerted effects in septic mice similar to those observed with GAS5 overexpression. In conclusion, GAS5 ameliorates sepsis-triggered intestinal barrier disruption by mediating the miR-223-3p/FBXW7 axis and inactivating NF-κB signaling. © 2025 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords: FBXW7; GAS5; NF‐κB; inflammation; intestinal barrier dysfunction; lipopolysaccharide; sepsis.
© 2025 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
NF-κB/miR-455-5p/SOCS3 Axis Aggravates Sepsis-Induced Acute Kidney Injury through Promoting Renal Inflammation.Nephron. 2025;149(2):104-115. doi: 10.1159/000541727. Epub 2024 Oct 8. Nephron. 2025. PMID: 39378861
-
miR-361-3p overexpression promotes apoptosis and inflammation by regulating the USP49/IκBα/NF-κB pathway to aggravate sepsis-induced myocardial injury.Toxicol Res (Camb). 2024 Nov 19;13(6):tfae190. doi: 10.1093/toxres/tfae190. eCollection 2024 Dec. Toxicol Res (Camb). 2024. PMID: 39568464
-
4-Octyl itaconate alleviates endothelial cell inflammation and barrier dysfunction in LPS-induced sepsis via modulating TLR4/MAPK/NF-κB signaling : 4-Octyl itaconate alleviates endothelial dysfunction.Mol Med. 2025 Jun 16;31(1):240. doi: 10.1186/s10020-025-01160-2. Mol Med. 2025. PMID: 40524158 Free PMC article.
-
Epigenetic Regulation by lncRNA GAS5/miRNA/mRNA Network in Human Diseases.Int J Mol Sci. 2025 Feb 6;26(3):1377. doi: 10.3390/ijms26031377. Int J Mol Sci. 2025. PMID: 39941145 Free PMC article. Review.
-
Dietary Carbohydrates and the Intestinal Barrier: Emerging Insights into NF-κB Modulation and Health Outcomes.J Agric Food Chem. 2025 Aug 27;73(34):21264-21282. doi: 10.1021/acs.jafc.5c06354. Epub 2025 Aug 19. J Agric Food Chem. 2025. PMID: 40827561 Review.
References
-
- Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis‐3). JAMA 2016; 315: 801–810.
-
- Giustozzi M, Ehrlinder H, Bongiovanni D, et al. Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment. Blood Rev 2021; 50: 100864.
-
- Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990‐2017: analysis for the global burden of disease study. Lancet 2020; 395: 200–211.
-
- Li B, Dou Z, Zhang L, et al. Ghrelin alleviates intestinal dysfunction in sepsis through the KLF4/MMP2 regulatory axis by activating SIRT1. Front Immunol 2021; 12: 646775.
-
- Wang M, Guo S, Zhang Y, et al. Remifentanil attenuates sepsis‐induced intestinal injury by inducing autophagy. Bioengineered 2021; 12: 9575–9584.
MeSH terms
Substances
Grants and funding
- WK2022ZF14/Young and Middle-aged Research Fund of Wannan Medical College
- KJ2021ZD0099/Natural Science Research Project of Colleges and Universities in Anhui Province
- YR202405/the Introduction to the Talents Special Research Start-up Fund Project of Yijishan Hospital
- 202427b10020039/Clinical and Translational Research Project of Anhui Province
LinkOut - more resources
Full Text Sources
Medical